PQBP1 Promotes Translational Elongation and Regulates Hippocampal Mglur-Ltd by Suppressing Eef2 Phosphorylation

Yuqian Shen,Zi Chao Zhang,Shanshan Cheng,An Liu,Jian Zuo,Shuting Xia,Xian Liu,Wenhua Liu,Zhengping Jia,Wei Xie,Junhai Han
DOI: https://doi.org/10.1016/j.molcel.2021.01.032
IF: 16
2021-01-01
Molecular Cell
Abstract:Eukaryotic elongation factor 2 (eEF2) mediates translocation of peptidyl-tRNA from the ribosomal A site to the P site to promote translational elongation. Its phosphorylation on Thr56 by its single known kinase eEF2K inactivates it and inhibits translational elongation. Extensive studies have revealed that different signal cascades modulate eEF2K activity, but whether additional factors regulate phosphorylation of eEF2 remains unclear, Here, we find that the X chromosome-linked intellectual disability protein polyglutaminebinding protein 1 (PQBP1) specifically binds to non-phosphorylated eEF2 and suppresses eEF2K-mediated phosphorylation at Thr56. Loss of PQBP1 significantly reduces general protein synthesis by suppressing translational elongation. Moreover, we show that PQBP1 regulates hippocampal metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) and mGluR-LTD-associated behaviors by suppressing eEF2K-mediated phosphorylation. Our results identify PQBP1 as a novel regulator in translational elongation and mGluR-LTD, and this newly revealed regulator in the eEF2K/eEF2 pathway is also an excellent therapeutic target for various disease conditions, such as neural diseases, virus infection, and cancer.
What problem does this paper attempt to address?